Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2023-08-16 00:00:00 ET · period of report 2023-08-14 · accession 0001209191-23-046018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-16 | 2023-08-14 | IRWD | Silver Ronald | Principal Accounting Off | S - Sale | $10.04 | -1,976 | 134.2K | -1% | -$19.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-08-14 | S | D | 1,976 | $10.04 | 134,172 | D | — | — | (F2) The reporting person acquired 2,037 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 30, 2023. |